韓國Bioneer
BIONEER公司是韓國KOSDAQ上市的著名生物科技企業(Kosdaq:064550),于1992年由樸翰浯(Han-Oh Park, Ph.D.)博士創建,總部設在韓國大田,擁有雄厚的科研實力,并承擔有韓國科技部大量研究項目。憑借優異的產品質量、先進的生產管理經驗,Bioneer通過了ISO9001和ISO13485產品質量體系認證。2005年在美國成立了全資子公司,并建有22,000平米的寡核苷酸合成基地。目前Bioneer在全球四十多個國家擁有銷售網絡,擁有全球最大的寡核苷酸合成規模,韓國國內外專利170多項,產品覆蓋生命科學、基因組學、基因診斷和基因治療等領域.
秉承“科技造福人類”的創業理念,Bioneer公司于2008年8月在中國成立了全資子公司——柏業貿易(上海)有限公司。我們將會以極具競爭力的價格提供一流的產品和專業的服務,期望能為中國廣大科研工作者提供幫助。請相信:在您成功走向科研殿堂的路上,Bioneer會忠誠地伴隨在您左右。
BIONEER公司主要產品:
儀器——全自動核酸提取儀、實時定量、梯度、常規PCR儀、混勻離心雙功能機、電泳系統等
試劑——DNA/RNA提取純化、獨特PCR Premix、酶及DNA標準物
合成服務——引物、探針、siRNA等合成及修飾服務
藥物開發——S.pombe藥物篩選系統
分子診斷試劑
Bioneer Corporation is the first Korean biotechnology company established in 1992. The company has developed state of art molecular biology products and technologies including oligonucleotides, thermostable polymerases, and instruments of gene manipulation (automatic nucleic acid extractor, thermal cycler, real-time QPCR instruments and DNA sequencer). From its inception, Bioneer has invested in the integration of recombinant DNA technology, fermentation, biochemistry and nucleic acid chemistry in addition to mechanics, photonics and electronics. The company is positioned to fully-integrate its capability to develop next generation technologies in the post-genome era through the invention of new biochemistry and instruments. Bioneer now runs two production and research facilities in Korea which are a total of 226,000 square feet. Equipped with proprietary 384 synthesizers, these facilities contain a full production line for oligonucleotide and siRNA synthesis. In addition to DNA manufacturing, Bioneer processes recombinant proteins which are fermented and purified on proprietary purification systems.
After a successful Initial Public Offering in December 2005, Bioneer Corp. launched Bioneer Inc., the wholly owned subsidiary. The American subsidiary is located in a 22,000 square foot production and distribution facility in Alameda, CA, the heart of the San Francisco Bay Area. The company is dedicated to providing state of art solutions to the global community of life science researchers in academia, biotech and pharmaceutical companies.